pubmed.ncbi.nlm.nih.gov

The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells - PubMed

  • ️Sat Jan 01 1994

The mechanism by which epidermal growth factor inhibits glycogen synthase kinase 3 in A431 cells

Y Saito et al. Biochem J. 1994.

Abstract

Glycogen synthase kinase 3 (GSK3) was inhibited by 50% within 5 min when A431 cells were stimulated with epidermal growth factor (EGF). The inhibition was unaffected by rapamycin at concentrations which blocked the activation of p70 S6 kinase, and reversed by incubation with protein phosphatase-1. EGF stimulation of A431 cells inhibited GSK3 alpha and GSK3 beta to a similar extent, and inhibition was accompanied by phosphorylation of the tryptic peptides containing the serine residues phosphorylated in vitro by p70 S6 kinase or MAP kinase-activated protein (MAPKAP) kinase-1 beta (also termed Rsk-2). These results demonstrate that EGF inhibits GSK3 by inducing phosphorylation of a serine residue and that GSK3 is not phosphorylated in vivo by either p70 S6 kinase or protein kinase C.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Anal Biochem. 1976 May 7;72:248-54 - PubMed
    1. Biochem J. 1992 Nov 15;288 ( Pt 1):309-14 - PubMed
    1. Anal Biochem. 1993 Jan;208(1):132-7 - PubMed
    1. EMBO J. 1993 Feb;12(2):803-8 - PubMed
    1. Nature. 1993 Apr 8;362(6420):557-60 - PubMed

Publication types

MeSH terms

Substances